FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

325072002: Insulin aspart (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
465704013 Insulin aspart en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
718291019 Insulin aspart (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3488039019 Insulin aspart soluble en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
465704013 Insulin aspart en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
465704013 Insulin aspart en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
718291019 Insulin aspart (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
718291019 Insulin aspart (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3488039019 Insulin aspart soluble en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
49301000195116 insulina aspartat it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
63441000195118 Insulin aspart de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
817901000172113 insuline asparte fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
817901000172113 insuline asparte fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
49301000195116 insulina aspartat it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
63441000195118 Insulin aspart de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
insulina aspartat Is a Insulin-containing product false Inferred relationship Existential restriction modifier (core metadata concept)
insulina aspartat Is a Human insulin (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
insulina aspartat Is a Short-acting insulin false Inferred relationship Existential restriction modifier (core metadata concept)
insulina aspartat Has disposition Pancreatic hormone (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
insuline aspart 100 unités/mL, flacon de 10 mL de solution injectable Is a False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart 100units/mL prefilled syringe Is a False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart 100units/mL cartridge Is a False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
insuline aspart 100 unités/mL, flacon de 10 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart 100units/mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart 100units/mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Product containing insulin aspart (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart 100units/mL injection solution 3mL prefilled disposable injection device The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml pre-filled disposable injection device The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart (recombinant human insulin analogue) 100units/ml injection 3ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart biphasic (recombinant human insulin analogue) 30/70 100units/ml injection 3ml cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart (recombinant human insulin analogue) 100units/ml inject The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Insulin aspart protamine Is a False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Product containing insulin aspart and insulin degludec (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 1
Insulin aspart- and insulin degludec-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing insulin aspart in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 1
Insulin aspart protamine Is modification of (attribute) False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely insulin aspart 1000 unit/10 milliliter conventional release solution for injection vial Has basis of strength substance (attribute) False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely insulin aspart 1000 unit/10 milliliter conventional release solution for injection vial Has precise active ingredient False insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only insulin aspart (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 1
Insulin aspart and insulin degludec only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 1
Insulin aspart and insulin degludec only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only insulin aspart in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 1
Insulin aspart 100 unit/mL solution for injection Has basis of strength substance (attribute) True insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 1
Insulin aspart 100 unit/mL solution for injection Has precise active ingredient True insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True insulina aspartat Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start